nodes	percent_of_prediction	percent_of_DWPC	metapath
Cyclobenzaprine—CYP3A4—bone cancer	0.915	1	CbGaD
Cyclobenzaprine—Olopatadine—CYP3A4—bone cancer	0.000657	0.17	CrCbGaD
Cyclobenzaprine—Alimemazine—CYP3A4—bone cancer	0.0006	0.155	CrCbGaD
Cyclobenzaprine—Gynaecomastia—Methotrexate—bone cancer	0.000528	0.00648	CcSEcCtD
Cyclobenzaprine—Atrioventricular block—Doxorubicin—bone cancer	0.000526	0.00647	CcSEcCtD
Cyclobenzaprine—Gait disturbance—Doxorubicin—bone cancer	0.000523	0.00643	CcSEcCtD
Cyclobenzaprine—Coordination abnormal—Doxorubicin—bone cancer	0.00052	0.00639	CcSEcCtD
Cyclobenzaprine—Tinnitus—Cisplatin—bone cancer	0.000503	0.00618	CcSEcCtD
Cyclobenzaprine—Hypertonia—Epirubicin—bone cancer	0.000484	0.00594	CcSEcCtD
Cyclobenzaprine—Arrhythmia—Cisplatin—bone cancer	0.000482	0.00592	CcSEcCtD
Cyclobenzaprine—Mental disability—Epirubicin—bone cancer	0.000479	0.00588	CcSEcCtD
Cyclobenzaprine—Alopecia—Cisplatin—bone cancer	0.000477	0.00586	CcSEcCtD
Cyclobenzaprine—Flatulence—Cisplatin—bone cancer	0.000463	0.00569	CcSEcCtD
Cyclobenzaprine—Hepatic function abnormal—Epirubicin—bone cancer	0.000458	0.00563	CcSEcCtD
Cyclobenzaprine—Vascular purpura—Epirubicin—bone cancer	0.000448	0.0055	CcSEcCtD
Cyclobenzaprine—Hypertonia—Doxorubicin—bone cancer	0.000448	0.0055	CcSEcCtD
Cyclobenzaprine—Mental disability—Doxorubicin—bone cancer	0.000443	0.00544	CcSEcCtD
Cyclobenzaprine—Vision blurred—Cisplatin—bone cancer	0.000443	0.00544	CcSEcCtD
Cyclobenzaprine—Tremor—Cisplatin—bone cancer	0.00044	0.00541	CcSEcCtD
Cyclobenzaprine—Cerebrovascular accident—Methotrexate—bone cancer	0.000437	0.00537	CcSEcCtD
Cyclobenzaprine—Ill-defined disorder—Cisplatin—bone cancer	0.000436	0.00536	CcSEcCtD
Cyclobenzaprine—Osteoarthritis—Methotrexate—bone cancer	0.000428	0.00526	CcSEcCtD
Cyclobenzaprine—Hepatic function abnormal—Doxorubicin—bone cancer	0.000424	0.00521	CcSEcCtD
Cyclobenzaprine—Malaise—Cisplatin—bone cancer	0.000424	0.00521	CcSEcCtD
Cyclobenzaprine—Leukopenia—Cisplatin—bone cancer	0.00042	0.00517	CcSEcCtD
Cyclobenzaprine—Purpura—Epirubicin—bone cancer	0.000416	0.00511	CcSEcCtD
Cyclobenzaprine—Vascular purpura—Doxorubicin—bone cancer	0.000414	0.00509	CcSEcCtD
Cyclobenzaprine—Cerebrovascular accident—Epirubicin—bone cancer	0.000409	0.00502	CcSEcCtD
Cyclobenzaprine—Irritability—Methotrexate—bone cancer	0.000409	0.00502	CcSEcCtD
Cyclobenzaprine—Convulsion—Cisplatin—bone cancer	0.000407	0.005	CcSEcCtD
Cyclobenzaprine—Ataxia—Methotrexate—bone cancer	0.000402	0.00495	CcSEcCtD
Cyclobenzaprine—Diplopia—Epirubicin—bone cancer	0.000401	0.00492	CcSEcCtD
Cyclobenzaprine—Osteoarthritis—Epirubicin—bone cancer	0.000401	0.00492	CcSEcCtD
Cyclobenzaprine—Myalgia—Cisplatin—bone cancer	0.0004	0.00491	CcSEcCtD
Cyclobenzaprine—Anxiety—Cisplatin—bone cancer	0.000399	0.0049	CcSEcCtD
Cyclobenzaprine—Discomfort—Cisplatin—bone cancer	0.000395	0.00486	CcSEcCtD
Cyclobenzaprine—Face oedema—Epirubicin—bone cancer	0.000387	0.00475	CcSEcCtD
Cyclobenzaprine—Purpura—Doxorubicin—bone cancer	0.000385	0.00473	CcSEcCtD
Cyclobenzaprine—Oedema—Cisplatin—bone cancer	0.000383	0.00471	CcSEcCtD
Cyclobenzaprine—Anaphylactic shock—Cisplatin—bone cancer	0.000383	0.00471	CcSEcCtD
Cyclobenzaprine—Cerebrovascular accident—Doxorubicin—bone cancer	0.000378	0.00465	CcSEcCtD
Cyclobenzaprine—Ataxia—Epirubicin—bone cancer	0.000377	0.00463	CcSEcCtD
Cyclobenzaprine—Thrombocytopenia—Cisplatin—bone cancer	0.000375	0.00461	CcSEcCtD
Cyclobenzaprine—Tachycardia—Cisplatin—bone cancer	0.000374	0.0046	CcSEcCtD
Cyclobenzaprine—Diplopia—Doxorubicin—bone cancer	0.000371	0.00455	CcSEcCtD
Cyclobenzaprine—Osteoarthritis—Doxorubicin—bone cancer	0.000371	0.00455	CcSEcCtD
Cyclobenzaprine—Hyperhidrosis—Cisplatin—bone cancer	0.000371	0.00455	CcSEcCtD
Cyclobenzaprine—Eosinophilia—Methotrexate—bone cancer	0.000366	0.0045	CcSEcCtD
Cyclobenzaprine—Anorexia—Cisplatin—bone cancer	0.000365	0.00449	CcSEcCtD
Cyclobenzaprine—Hypotension—Cisplatin—bone cancer	0.000358	0.0044	CcSEcCtD
Cyclobenzaprine—Face oedema—Doxorubicin—bone cancer	0.000358	0.0044	CcSEcCtD
Cyclobenzaprine—Gastritis—Epirubicin—bone cancer	0.000355	0.00436	CcSEcCtD
Cyclobenzaprine—Pancytopenia—Methotrexate—bone cancer	0.000351	0.00432	CcSEcCtD
Cyclobenzaprine—Musculoskeletal discomfort—Cisplatin—bone cancer	0.000349	0.00429	CcSEcCtD
Cyclobenzaprine—Ataxia—Doxorubicin—bone cancer	0.000349	0.00428	CcSEcCtD
Cyclobenzaprine—Carbamazepine—CYP3A4—bone cancer	0.000344	0.0893	CrCbGaD
Cyclobenzaprine—Paraesthesia—Cisplatin—bone cancer	0.000344	0.00423	CcSEcCtD
Cyclobenzaprine—Upper respiratory tract infection—Methotrexate—bone cancer	0.000344	0.00423	CcSEcCtD
Cyclobenzaprine—Eosinophilia—Epirubicin—bone cancer	0.000343	0.00421	CcSEcCtD
Cyclobenzaprine—Dyspnoea—Cisplatin—bone cancer	0.000342	0.0042	CcSEcCtD
Cyclobenzaprine—Erectile dysfunction—Methotrexate—bone cancer	0.000341	0.00419	CcSEcCtD
Cyclobenzaprine—Decreased appetite—Cisplatin—bone cancer	0.000333	0.0041	CcSEcCtD
Cyclobenzaprine—Drowsiness—Methotrexate—bone cancer	0.00033	0.00405	CcSEcCtD
Cyclobenzaprine—Pancytopenia—Epirubicin—bone cancer	0.000329	0.00404	CcSEcCtD
Cyclobenzaprine—Gastritis—Doxorubicin—bone cancer	0.000328	0.00403	CcSEcCtD
Cyclobenzaprine—Benzphetamine—CYP3A4—bone cancer	0.000327	0.0848	CrCbGaD
Cyclobenzaprine—Upper respiratory tract infection—Epirubicin—bone cancer	0.000322	0.00395	CcSEcCtD
Cyclobenzaprine—Stomatitis—Methotrexate—bone cancer	0.000322	0.00395	CcSEcCtD
Cyclobenzaprine—Pollakiuria—Epirubicin—bone cancer	0.00032	0.00393	CcSEcCtD
Cyclobenzaprine—Eosinophilia—Doxorubicin—bone cancer	0.000317	0.0039	CcSEcCtD
Cyclobenzaprine—Sweating—Methotrexate—bone cancer	0.000316	0.00389	CcSEcCtD
Cyclobenzaprine—Feeling abnormal—Cisplatin—bone cancer	0.000316	0.00388	CcSEcCtD
Cyclobenzaprine—Weight increased—Epirubicin—bone cancer	0.000315	0.00387	CcSEcCtD
Cyclobenzaprine—Drowsiness—Epirubicin—bone cancer	0.000309	0.00379	CcSEcCtD
Cyclobenzaprine—Agranulocytosis—Methotrexate—bone cancer	0.000308	0.00378	CcSEcCtD
Cyclobenzaprine—Pancytopenia—Doxorubicin—bone cancer	0.000304	0.00374	CcSEcCtD
Cyclobenzaprine—Neuropathy peripheral—Epirubicin—bone cancer	0.000303	0.00372	CcSEcCtD
Cyclobenzaprine—Stomatitis—Epirubicin—bone cancer	0.000301	0.0037	CcSEcCtD
Cyclobenzaprine—Jaundice—Epirubicin—bone cancer	0.000301	0.0037	CcSEcCtD
Cyclobenzaprine—Upper respiratory tract infection—Doxorubicin—bone cancer	0.000298	0.00366	CcSEcCtD
Cyclobenzaprine—Hepatitis—Methotrexate—bone cancer	0.000296	0.00364	CcSEcCtD
Cyclobenzaprine—Sweating—Epirubicin—bone cancer	0.000296	0.00364	CcSEcCtD
Cyclobenzaprine—Pollakiuria—Doxorubicin—bone cancer	0.000296	0.00364	CcSEcCtD
Cyclobenzaprine—Pharyngitis—Methotrexate—bone cancer	0.000294	0.00361	CcSEcCtD
Cyclobenzaprine—Weight increased—Doxorubicin—bone cancer	0.000292	0.00358	CcSEcCtD
Cyclobenzaprine—Agranulocytosis—Epirubicin—bone cancer	0.000288	0.00354	CcSEcCtD
Cyclobenzaprine—Drowsiness—Doxorubicin—bone cancer	0.000286	0.00351	CcSEcCtD
Cyclobenzaprine—Nortriptyline—CYP3A4—bone cancer	0.000284	0.0735	CrCbGaD
Cyclobenzaprine—Hypersensitivity—Cisplatin—bone cancer	0.000282	0.00347	CcSEcCtD
Cyclobenzaprine—Neuropathy peripheral—Doxorubicin—bone cancer	0.00028	0.00344	CcSEcCtD
Cyclobenzaprine—Stomatitis—Doxorubicin—bone cancer	0.000278	0.00342	CcSEcCtD
Cyclobenzaprine—Jaundice—Doxorubicin—bone cancer	0.000278	0.00342	CcSEcCtD
Cyclobenzaprine—Hepatitis—Epirubicin—bone cancer	0.000277	0.00341	CcSEcCtD
Cyclobenzaprine—Tinnitus—Methotrexate—bone cancer	0.000276	0.00339	CcSEcCtD
Cyclobenzaprine—Hypoaesthesia—Epirubicin—bone cancer	0.000276	0.00339	CcSEcCtD
Cyclobenzaprine—Asthenia—Cisplatin—bone cancer	0.000275	0.00338	CcSEcCtD
Cyclobenzaprine—Pharyngitis—Epirubicin—bone cancer	0.000275	0.00338	CcSEcCtD
Cyclobenzaprine—Sweating—Doxorubicin—bone cancer	0.000274	0.00336	CcSEcCtD
Cyclobenzaprine—Trimipramine—CYP3A4—bone cancer	0.000267	0.0692	CrCbGaD
Cyclobenzaprine—Agranulocytosis—Doxorubicin—bone cancer	0.000267	0.00328	CcSEcCtD
Cyclobenzaprine—Diarrhoea—Cisplatin—bone cancer	0.000262	0.00322	CcSEcCtD
Cyclobenzaprine—Alopecia—Methotrexate—bone cancer	0.000262	0.00322	CcSEcCtD
Cyclobenzaprine—Tinnitus—Epirubicin—bone cancer	0.000258	0.00317	CcSEcCtD
Cyclobenzaprine—Hepatitis—Doxorubicin—bone cancer	0.000256	0.00315	CcSEcCtD
Cyclobenzaprine—Tamoxifen—CYP3A4—bone cancer	0.000255	0.0662	CrCbGaD
Cyclobenzaprine—Hypoaesthesia—Doxorubicin—bone cancer	0.000255	0.00313	CcSEcCtD
Cyclobenzaprine—Pharyngitis—Doxorubicin—bone cancer	0.000254	0.00313	CcSEcCtD
Cyclobenzaprine—Doxepin—CYP3A4—bone cancer	0.000254	0.066	CrCbGaD
Cyclobenzaprine—Dysgeusia—Methotrexate—bone cancer	0.000252	0.0031	CcSEcCtD
Cyclobenzaprine—Orphenadrine—CYP3A4—bone cancer	0.000248	0.0643	CrCbGaD
Cyclobenzaprine—Arrhythmia—Epirubicin—bone cancer	0.000248	0.00304	CcSEcCtD
Cyclobenzaprine—Alopecia—Epirubicin—bone cancer	0.000245	0.00301	CcSEcCtD
Cyclobenzaprine—Vomiting—Cisplatin—bone cancer	0.000244	0.003	CcSEcCtD
Cyclobenzaprine—Vision blurred—Methotrexate—bone cancer	0.000243	0.00299	CcSEcCtD
Cyclobenzaprine—Rash—Cisplatin—bone cancer	0.000242	0.00297	CcSEcCtD
Cyclobenzaprine—Dermatitis—Cisplatin—bone cancer	0.000242	0.00297	CcSEcCtD
Cyclobenzaprine—Ill-defined disorder—Methotrexate—bone cancer	0.000239	0.00294	CcSEcCtD
Cyclobenzaprine—Tinnitus—Doxorubicin—bone cancer	0.000239	0.00294	CcSEcCtD
Cyclobenzaprine—Flatulence—Epirubicin—bone cancer	0.000238	0.00292	CcSEcCtD
Cyclobenzaprine—Tension—Epirubicin—bone cancer	0.000237	0.00291	CcSEcCtD
Cyclobenzaprine—Dysgeusia—Epirubicin—bone cancer	0.000236	0.0029	CcSEcCtD
Cyclobenzaprine—Nervousness—Epirubicin—bone cancer	0.000234	0.00288	CcSEcCtD
Cyclobenzaprine—Malaise—Methotrexate—bone cancer	0.000232	0.00286	CcSEcCtD
Cyclobenzaprine—Vertigo—Methotrexate—bone cancer	0.000232	0.00285	CcSEcCtD
Cyclobenzaprine—Leukopenia—Methotrexate—bone cancer	0.000231	0.00284	CcSEcCtD
Cyclobenzaprine—Arrhythmia—Doxorubicin—bone cancer	0.000229	0.00281	CcSEcCtD
Cyclobenzaprine—Nausea—Cisplatin—bone cancer	0.000228	0.0028	CcSEcCtD
Cyclobenzaprine—Vision blurred—Epirubicin—bone cancer	0.000227	0.00279	CcSEcCtD
Cyclobenzaprine—Alopecia—Doxorubicin—bone cancer	0.000227	0.00278	CcSEcCtD
Cyclobenzaprine—Promazine—CYP3A4—bone cancer	0.000226	0.0586	CrCbGaD
Cyclobenzaprine—Ill-defined disorder—Epirubicin—bone cancer	0.000224	0.00275	CcSEcCtD
Cyclobenzaprine—Convulsion—Methotrexate—bone cancer	0.000223	0.00274	CcSEcCtD
Cyclobenzaprine—Agitation—Epirubicin—bone cancer	0.000222	0.00272	CcSEcCtD
Cyclobenzaprine—Flatulence—Doxorubicin—bone cancer	0.00022	0.0027	CcSEcCtD
Cyclobenzaprine—Chest pain—Methotrexate—bone cancer	0.000219	0.0027	CcSEcCtD
Cyclobenzaprine—Myalgia—Methotrexate—bone cancer	0.000219	0.0027	CcSEcCtD
Cyclobenzaprine—Tension—Doxorubicin—bone cancer	0.000219	0.00269	CcSEcCtD
Cyclobenzaprine—Dysgeusia—Doxorubicin—bone cancer	0.000219	0.00269	CcSEcCtD
Cyclobenzaprine—Malaise—Epirubicin—bone cancer	0.000218	0.00267	CcSEcCtD
Cyclobenzaprine—Discomfort—Methotrexate—bone cancer	0.000217	0.00266	CcSEcCtD
Cyclobenzaprine—Nervousness—Doxorubicin—bone cancer	0.000217	0.00266	CcSEcCtD
Cyclobenzaprine—Vertigo—Epirubicin—bone cancer	0.000217	0.00266	CcSEcCtD
Cyclobenzaprine—Syncope—Epirubicin—bone cancer	0.000216	0.00266	CcSEcCtD
Cyclobenzaprine—Leukopenia—Epirubicin—bone cancer	0.000216	0.00265	CcSEcCtD
Cyclobenzaprine—Palpitations—Epirubicin—bone cancer	0.000213	0.00262	CcSEcCtD
Cyclobenzaprine—Confusional state—Methotrexate—bone cancer	0.000212	0.00261	CcSEcCtD
Cyclobenzaprine—Loss of consciousness—Epirubicin—bone cancer	0.000212	0.00261	CcSEcCtD
Cyclobenzaprine—Anaphylactic shock—Methotrexate—bone cancer	0.00021	0.00259	CcSEcCtD
Cyclobenzaprine—Vision blurred—Doxorubicin—bone cancer	0.00021	0.00258	CcSEcCtD
Cyclobenzaprine—Convulsion—Epirubicin—bone cancer	0.000209	0.00257	CcSEcCtD
Cyclobenzaprine—Hypertension—Epirubicin—bone cancer	0.000208	0.00256	CcSEcCtD
Cyclobenzaprine—Ill-defined disorder—Doxorubicin—bone cancer	0.000207	0.00254	CcSEcCtD
Cyclobenzaprine—Thrombocytopenia—Methotrexate—bone cancer	0.000206	0.00253	CcSEcCtD
Cyclobenzaprine—Myalgia—Epirubicin—bone cancer	0.000205	0.00252	CcSEcCtD
Cyclobenzaprine—Chest pain—Epirubicin—bone cancer	0.000205	0.00252	CcSEcCtD
Cyclobenzaprine—Agitation—Doxorubicin—bone cancer	0.000205	0.00252	CcSEcCtD
Cyclobenzaprine—Anxiety—Epirubicin—bone cancer	0.000205	0.00251	CcSEcCtD
Cyclobenzaprine—Hyperhidrosis—Methotrexate—bone cancer	0.000203	0.0025	CcSEcCtD
Cyclobenzaprine—Discomfort—Epirubicin—bone cancer	0.000203	0.00249	CcSEcCtD
Cyclobenzaprine—Malaise—Doxorubicin—bone cancer	0.000201	0.00247	CcSEcCtD
Cyclobenzaprine—Dry mouth—Epirubicin—bone cancer	0.000201	0.00247	CcSEcCtD
Cyclobenzaprine—Vertigo—Doxorubicin—bone cancer	0.000201	0.00246	CcSEcCtD
Cyclobenzaprine—Anorexia—Methotrexate—bone cancer	0.000201	0.00246	CcSEcCtD
Cyclobenzaprine—Syncope—Doxorubicin—bone cancer	0.0002	0.00246	CcSEcCtD
Cyclobenzaprine—Leukopenia—Doxorubicin—bone cancer	0.0002	0.00246	CcSEcCtD
Cyclobenzaprine—Confusional state—Epirubicin—bone cancer	0.000199	0.00244	CcSEcCtD
Cyclobenzaprine—Imipramine—CYP3A4—bone cancer	0.000198	0.0513	CrCbGaD
Cyclobenzaprine—Palpitations—Doxorubicin—bone cancer	0.000197	0.00242	CcSEcCtD
Cyclobenzaprine—Anaphylactic shock—Epirubicin—bone cancer	0.000197	0.00242	CcSEcCtD
Cyclobenzaprine—Oedema—Epirubicin—bone cancer	0.000197	0.00242	CcSEcCtD
Cyclobenzaprine—Amitriptyline—CYP3A4—bone cancer	0.000197	0.051	CrCbGaD
Cyclobenzaprine—Hypotension—Methotrexate—bone cancer	0.000197	0.00242	CcSEcCtD
Cyclobenzaprine—Loss of consciousness—Doxorubicin—bone cancer	0.000196	0.00241	CcSEcCtD
Cyclobenzaprine—Shock—Epirubicin—bone cancer	0.000194	0.00238	CcSEcCtD
Cyclobenzaprine—Convulsion—Doxorubicin—bone cancer	0.000193	0.00238	CcSEcCtD
Cyclobenzaprine—Thrombocytopenia—Epirubicin—bone cancer	0.000193	0.00237	CcSEcCtD
Cyclobenzaprine—Hypertension—Doxorubicin—bone cancer	0.000193	0.00237	CcSEcCtD
Cyclobenzaprine—Tachycardia—Epirubicin—bone cancer	0.000192	0.00236	CcSEcCtD
Cyclobenzaprine—Musculoskeletal discomfort—Methotrexate—bone cancer	0.000192	0.00236	CcSEcCtD
Cyclobenzaprine—Hyperhidrosis—Epirubicin—bone cancer	0.00019	0.00234	CcSEcCtD
Cyclobenzaprine—Insomnia—Methotrexate—bone cancer	0.00019	0.00234	CcSEcCtD
Cyclobenzaprine—Chest pain—Doxorubicin—bone cancer	0.00019	0.00234	CcSEcCtD
Cyclobenzaprine—Myalgia—Doxorubicin—bone cancer	0.00019	0.00234	CcSEcCtD
Cyclobenzaprine—Anxiety—Doxorubicin—bone cancer	0.000189	0.00233	CcSEcCtD
Cyclobenzaprine—Paraesthesia—Methotrexate—bone cancer	0.000189	0.00232	CcSEcCtD
Cyclobenzaprine—Discomfort—Doxorubicin—bone cancer	0.000188	0.00231	CcSEcCtD
Cyclobenzaprine—Anorexia—Epirubicin—bone cancer	0.000188	0.00231	CcSEcCtD
Cyclobenzaprine—Dyspnoea—Methotrexate—bone cancer	0.000188	0.0023	CcSEcCtD
Cyclobenzaprine—Somnolence—Methotrexate—bone cancer	0.000187	0.0023	CcSEcCtD
Cyclobenzaprine—Dry mouth—Doxorubicin—bone cancer	0.000186	0.00228	CcSEcCtD
Cyclobenzaprine—Dyspepsia—Methotrexate—bone cancer	0.000185	0.00228	CcSEcCtD
Cyclobenzaprine—Hypotension—Epirubicin—bone cancer	0.000184	0.00226	CcSEcCtD
Cyclobenzaprine—Confusional state—Doxorubicin—bone cancer	0.000184	0.00226	CcSEcCtD
Cyclobenzaprine—Decreased appetite—Methotrexate—bone cancer	0.000183	0.00225	CcSEcCtD
Cyclobenzaprine—Anaphylactic shock—Doxorubicin—bone cancer	0.000182	0.00224	CcSEcCtD
Cyclobenzaprine—Oedema—Doxorubicin—bone cancer	0.000182	0.00224	CcSEcCtD
Cyclobenzaprine—Fatigue—Methotrexate—bone cancer	0.000181	0.00223	CcSEcCtD
Cyclobenzaprine—Musculoskeletal discomfort—Epirubicin—bone cancer	0.000179	0.0022	CcSEcCtD
Cyclobenzaprine—Shock—Doxorubicin—bone cancer	0.000179	0.0022	CcSEcCtD
Cyclobenzaprine—Thrombocytopenia—Doxorubicin—bone cancer	0.000178	0.00219	CcSEcCtD
Cyclobenzaprine—Insomnia—Epirubicin—bone cancer	0.000178	0.00219	CcSEcCtD
Cyclobenzaprine—Tachycardia—Doxorubicin—bone cancer	0.000178	0.00218	CcSEcCtD
Cyclobenzaprine—Paraesthesia—Epirubicin—bone cancer	0.000177	0.00217	CcSEcCtD
Cyclobenzaprine—Hyperhidrosis—Doxorubicin—bone cancer	0.000176	0.00216	CcSEcCtD
Cyclobenzaprine—Dyspnoea—Epirubicin—bone cancer	0.000176	0.00216	CcSEcCtD
Cyclobenzaprine—Somnolence—Epirubicin—bone cancer	0.000175	0.00215	CcSEcCtD
Cyclobenzaprine—Anorexia—Doxorubicin—bone cancer	0.000174	0.00213	CcSEcCtD
Cyclobenzaprine—Feeling abnormal—Methotrexate—bone cancer	0.000173	0.00213	CcSEcCtD
Cyclobenzaprine—Dyspepsia—Epirubicin—bone cancer	0.000173	0.00213	CcSEcCtD
Cyclobenzaprine—Gastrointestinal pain—Methotrexate—bone cancer	0.000172	0.00211	CcSEcCtD
Cyclobenzaprine—Decreased appetite—Epirubicin—bone cancer	0.000171	0.0021	CcSEcCtD
Cyclobenzaprine—Hypotension—Doxorubicin—bone cancer	0.00017	0.00209	CcSEcCtD
Cyclobenzaprine—Fatigue—Epirubicin—bone cancer	0.00017	0.00209	CcSEcCtD
Cyclobenzaprine—Constipation—Epirubicin—bone cancer	0.000168	0.00207	CcSEcCtD
Cyclobenzaprine—Urticaria—Methotrexate—bone cancer	0.000167	0.00205	CcSEcCtD
Cyclobenzaprine—Abdominal pain—Methotrexate—bone cancer	0.000166	0.00204	CcSEcCtD
Cyclobenzaprine—Musculoskeletal discomfort—Doxorubicin—bone cancer	0.000166	0.00204	CcSEcCtD
Cyclobenzaprine—Insomnia—Doxorubicin—bone cancer	0.000165	0.00202	CcSEcCtD
Cyclobenzaprine—Paraesthesia—Doxorubicin—bone cancer	0.000164	0.00201	CcSEcCtD
Cyclobenzaprine—Dyspnoea—Doxorubicin—bone cancer	0.000162	0.002	CcSEcCtD
Cyclobenzaprine—Feeling abnormal—Epirubicin—bone cancer	0.000162	0.00199	CcSEcCtD
Cyclobenzaprine—Somnolence—Doxorubicin—bone cancer	0.000162	0.00199	CcSEcCtD
Cyclobenzaprine—Gastrointestinal pain—Epirubicin—bone cancer	0.000161	0.00198	CcSEcCtD
Cyclobenzaprine—Dyspepsia—Doxorubicin—bone cancer	0.00016	0.00197	CcSEcCtD
Cyclobenzaprine—Decreased appetite—Doxorubicin—bone cancer	0.000158	0.00195	CcSEcCtD
Cyclobenzaprine—Fatigue—Doxorubicin—bone cancer	0.000157	0.00193	CcSEcCtD
Cyclobenzaprine—Urticaria—Epirubicin—bone cancer	0.000156	0.00192	CcSEcCtD
Cyclobenzaprine—Constipation—Doxorubicin—bone cancer	0.000156	0.00191	CcSEcCtD
Cyclobenzaprine—Abdominal pain—Epirubicin—bone cancer	0.000156	0.00191	CcSEcCtD
Cyclobenzaprine—Hypersensitivity—Methotrexate—bone cancer	0.000155	0.0019	CcSEcCtD
Cyclobenzaprine—Asthenia—Methotrexate—bone cancer	0.000151	0.00185	CcSEcCtD
Cyclobenzaprine—Feeling abnormal—Doxorubicin—bone cancer	0.00015	0.00184	CcSEcCtD
Cyclobenzaprine—Gastrointestinal pain—Doxorubicin—bone cancer	0.000149	0.00183	CcSEcCtD
Cyclobenzaprine—Pruritus—Methotrexate—bone cancer	0.000149	0.00183	CcSEcCtD
Cyclobenzaprine—Hypersensitivity—Epirubicin—bone cancer	0.000145	0.00178	CcSEcCtD
Cyclobenzaprine—Urticaria—Doxorubicin—bone cancer	0.000145	0.00178	CcSEcCtD
Cyclobenzaprine—Abdominal pain—Doxorubicin—bone cancer	0.000144	0.00177	CcSEcCtD
Cyclobenzaprine—Diarrhoea—Methotrexate—bone cancer	0.000144	0.00177	CcSEcCtD
Cyclobenzaprine—Asthenia—Epirubicin—bone cancer	0.000141	0.00174	CcSEcCtD
Cyclobenzaprine—Pruritus—Epirubicin—bone cancer	0.000139	0.00171	CcSEcCtD
Cyclobenzaprine—Dizziness—Methotrexate—bone cancer	0.000139	0.00171	CcSEcCtD
Cyclobenzaprine—Diarrhoea—Epirubicin—bone cancer	0.000135	0.00166	CcSEcCtD
Cyclobenzaprine—Hypersensitivity—Doxorubicin—bone cancer	0.000134	0.00165	CcSEcCtD
Cyclobenzaprine—Vomiting—Methotrexate—bone cancer	0.000134	0.00164	CcSEcCtD
Cyclobenzaprine—Rash—Methotrexate—bone cancer	0.000133	0.00163	CcSEcCtD
Cyclobenzaprine—Dermatitis—Methotrexate—bone cancer	0.000133	0.00163	CcSEcCtD
Cyclobenzaprine—Headache—Methotrexate—bone cancer	0.000132	0.00162	CcSEcCtD
Cyclobenzaprine—Asthenia—Doxorubicin—bone cancer	0.000131	0.00161	CcSEcCtD
Cyclobenzaprine—Dizziness—Epirubicin—bone cancer	0.00013	0.0016	CcSEcCtD
Cyclobenzaprine—Pruritus—Doxorubicin—bone cancer	0.000129	0.00158	CcSEcCtD
Cyclobenzaprine—Vomiting—Epirubicin—bone cancer	0.000125	0.00154	CcSEcCtD
Cyclobenzaprine—Nausea—Methotrexate—bone cancer	0.000125	0.00154	CcSEcCtD
Cyclobenzaprine—Diarrhoea—Doxorubicin—bone cancer	0.000125	0.00153	CcSEcCtD
Cyclobenzaprine—Rash—Epirubicin—bone cancer	0.000124	0.00153	CcSEcCtD
Cyclobenzaprine—Dermatitis—Epirubicin—bone cancer	0.000124	0.00152	CcSEcCtD
Cyclobenzaprine—Headache—Epirubicin—bone cancer	0.000123	0.00152	CcSEcCtD
Cyclobenzaprine—Dizziness—Doxorubicin—bone cancer	0.00012	0.00148	CcSEcCtD
Cyclobenzaprine—Nausea—Epirubicin—bone cancer	0.000117	0.00144	CcSEcCtD
Cyclobenzaprine—Vomiting—Doxorubicin—bone cancer	0.000116	0.00142	CcSEcCtD
Cyclobenzaprine—Rash—Doxorubicin—bone cancer	0.000115	0.00141	CcSEcCtD
Cyclobenzaprine—Dermatitis—Doxorubicin—bone cancer	0.000115	0.00141	CcSEcCtD
Cyclobenzaprine—Headache—Doxorubicin—bone cancer	0.000114	0.0014	CcSEcCtD
Cyclobenzaprine—Nausea—Doxorubicin—bone cancer	0.000108	0.00133	CcSEcCtD
